KR102323339B1 - 정맥내 항바이러스 치료 - Google Patents

정맥내 항바이러스 치료 Download PDF

Info

Publication number
KR102323339B1
KR102323339B1 KR1020217018500A KR20217018500A KR102323339B1 KR 102323339 B1 KR102323339 B1 KR 102323339B1 KR 1020217018500 A KR1020217018500 A KR 1020217018500A KR 20217018500 A KR20217018500 A KR 20217018500A KR 102323339 B1 KR102323339 B1 KR 102323339B1
Authority
KR
South Korea
Prior art keywords
formula
compound
certain embodiments
iii
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217018500A
Other languages
English (en)
Korean (ko)
Other versions
KR20210076189A (ko
Inventor
얄라가따 수타카라 바부
푸란 챈드
샨타 반티아
쉐인 아놀드
존 마이클 킬패트릭
Original Assignee
바이오크리스트 파마수티컬즈, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38169715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102323339(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2006/013535 external-priority patent/WO2007117241A1/en
Application filed by 바이오크리스트 파마수티컬즈, 인코퍼레이티드 filed Critical 바이오크리스트 파마수티컬즈, 인코퍼레이티드
Priority to KR1020217035812A priority Critical patent/KR102475176B1/ko
Publication of KR20210076189A publication Critical patent/KR20210076189A/ko
Application granted granted Critical
Publication of KR102323339B1 publication Critical patent/KR102323339B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020217018500A 2006-02-13 2007-02-12 정맥내 항바이러스 치료 Active KR102323339B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217035812A KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US77274806P 2006-02-13 2006-02-13
US60/772,748 2006-02-13
USPCT/US2006/013535 2006-04-12
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments
KR1020207036259A KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
PCT/US2007/003755 WO2007095218A1 (en) 2006-02-13 2007-02-12 Intravenous antiviral treatments

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020207036259A Division KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217035812A Division KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Publications (2)

Publication Number Publication Date
KR20210076189A KR20210076189A (ko) 2021-06-23
KR102323339B1 true KR102323339B1 (ko) 2021-11-08

Family

ID=38169715

Family Applications (9)

Application Number Title Priority Date Filing Date
KR1020217018500A Active KR102323339B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020197017311A Active KR102194015B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020087022406A Ceased KR20080096829A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020207036259A Active KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020187005451A Ceased KR101992585B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020167030296A Ceased KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217035812A Active KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR20147030611A Ceased KR20140132778A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020227042429A Ceased KR20230003248A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Family Applications After (8)

Application Number Title Priority Date Filing Date
KR1020197017311A Active KR102194015B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020087022406A Ceased KR20080096829A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020207036259A Active KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020187005451A Ceased KR101992585B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020167030296A Ceased KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217035812A Active KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR20147030611A Ceased KR20140132778A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020227042429A Ceased KR20230003248A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Country Status (11)

Country Link
EP (1) EP1986626A1 (enExample)
JP (3) JP2009538822A (enExample)
KR (9) KR102323339B1 (enExample)
AU (2) AU2007215156A1 (enExample)
BR (1) BRPI0707769A2 (enExample)
CA (1) CA2642260C (enExample)
EA (1) EA025483B1 (enExample)
HK (1) HK1212250A1 (enExample)
MX (2) MX393640B (enExample)
MY (1) MY166063A (enExample)
WO (1) WO2007095218A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102323339B1 (ko) * 2006-02-13 2021-11-08 바이오크리스트 파마수티컬즈, 인코퍼레이티드 정맥내 항바이러스 치료
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
KR20220033561A (ko) 2020-09-07 2022-03-17 주식회사 경보제약 페라미비르 화합물을 포함하는 프리믹스 제형의 제약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263179T3 (es) * 1996-06-14 2006-12-01 Biocryst Pharmaceuticals Inc. Compuestos de clopentano sustituido como inhibidores de la neuraminidasa.
BR9813480A (pt) * 1997-12-17 2000-10-10 Biocryst Pharm Inc Compostos inibidores de neuraminidase de ciclopentano substituìdo, composição e métodos de inibição da neuraminidase do vìrus da influenza- e de tratamento de infecção por vìrus da influenza-
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
KR102323339B1 (ko) * 2006-02-13 2021-11-08 바이오크리스트 파마수티컬즈, 인코퍼레이티드 정맥내 항바이러스 치료

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Antiviral Research, 69(1), 39-45, 2006.
Bioorganic & Medicinal Chemistry, 13(12), 4071-4077, 2005.

Also Published As

Publication number Publication date
BRPI0707769A2 (pt) 2011-05-10
CA2642260A1 (en) 2007-08-23
KR102267754B1 (ko) 2021-06-23
KR20200143519A (ko) 2020-12-23
KR20210135632A (ko) 2021-11-15
MX393640B (es) 2025-03-21
HK1212250A1 (en) 2016-06-10
EP1986626A1 (en) 2008-11-05
KR101992585B9 (ko) 2022-09-20
KR102475176B1 (ko) 2022-12-07
KR102194015B1 (ko) 2020-12-22
MX2008010394A (es) 2009-01-12
WO2007095218A1 (en) 2007-08-23
KR20160129105A (ko) 2016-11-08
KR20080096829A (ko) 2008-11-03
AU2013216632A1 (en) 2013-08-29
AU2013216632B2 (en) 2016-09-01
KR20140132778A (ko) 2014-11-18
CA2642260C (en) 2016-08-09
KR101992585B1 (ko) 2019-06-25
JP2015180695A (ja) 2015-10-15
KR20180024027A (ko) 2018-03-07
KR20210076189A (ko) 2021-06-23
JP6073202B2 (ja) 2017-02-01
EA200870263A1 (ru) 2009-06-30
EA025483B1 (ru) 2016-12-30
KR20230003248A (ko) 2023-01-05
MY166063A (en) 2018-05-23
KR20190072681A (ko) 2019-06-25
AU2007215156A1 (en) 2007-08-23
MX2020002008A (es) 2020-07-13
JP2013256527A (ja) 2013-12-26
JP2009538822A (ja) 2009-11-12

Similar Documents

Publication Publication Date Title
US11779585B2 (en) Method for treating coronavirus infections
US12121503B2 (en) Antiviral treatments
KR102323339B1 (ko) 정맥내 항바이러스 치료
JP2009538822A5 (enExample)
JP2009533428A (ja) 筋肉内抗ウイルス処置
AU2016262644A1 (en) Intravenous antiviral treatments
KR20080113099A (ko) 근육내 항바이러스 치료
US20110015264A1 (en) Intramuscular antiviral treatments

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20210616

Application number text: 1020207036259

Filing date: 20201216

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210716

Comment text: Request for Examination of Application

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210802

GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20211102

Application number text: 1020207036259

Filing date: 20201216

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20211102

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20211103

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240620

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20250619

Start annual number: 5

End annual number: 5